The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal-derived Immune Globulin-Global Market Insights and Sales Trends 2024
Synopsis
The global Animal-derived Immune Globulin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animal-derived Immune Globulin in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Animal-derived Immune Globulin market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal-derived Immune Globulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal-derived Immune Globulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal-derived Immune Globulin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal-derived Immune Globulin covered in this report include Pfizer, Rare Disease Therapeutics, Merck, Sanofi, Wyeth Pharmaceuticals, Protherics and Genzyme, etc.
The global Animal-derived Immune Globulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Rare Disease Therapeutics
Merck
Sanofi
Wyeth Pharmaceuticals
Protherics
Genzyme
Global Animal-derived Immune Globulin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal-derived Immune Globulin market, Segment by Type:
Liquid
Powder
Global Animal-derived Immune Globulin market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal-derived Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Animal-derived Immune Globulin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animal-derived Immune Globulin in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Animal-derived Immune Globulin market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal-derived Immune Globulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal-derived Immune Globulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal-derived Immune Globulin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal-derived Immune Globulin covered in this report include Pfizer, Rare Disease Therapeutics, Merck, Sanofi, Wyeth Pharmaceuticals, Protherics and Genzyme, etc.
The global Animal-derived Immune Globulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Rare Disease Therapeutics
Merck
Sanofi
Wyeth Pharmaceuticals
Protherics
Genzyme
Global Animal-derived Immune Globulin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal-derived Immune Globulin market, Segment by Type:
Liquid
Powder
Global Animal-derived Immune Globulin market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal-derived Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Animal-derived Immune Globulin Market Overview
1.1 Animal-derived Immune Globulin Product Overview
1.2 Animal-derived Immune Globulin Market Segment by Type
1.2.1 Liquid
1.2.2 Powder
1.3 Global Animal-derived Immune Globulin Market Size by Type
1.3.1 Global Animal-derived Immune Globulin Market Size Overview by Type (2018-2029)
1.3.2 Global Animal-derived Immune Globulin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Animal-derived Immune Globulin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal-derived Immune Globulin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Animal-derived Immune Globulin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Animal-derived Immune Globulin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Animal-derived Immune Globulin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Animal-derived Immune Globulin Sales Breakdown by Type (2018-2023)
2 Global Animal-derived Immune Globulin Market Competition by Company
2.1 Global Top Players by Animal-derived Immune Globulin Sales (2018-2023)
2.2 Global Top Players by Animal-derived Immune Globulin Revenue (2018-2023)
2.3 Global Top Players by Animal-derived Immune Globulin Price (2018-2023)
2.4 Global Top Manufacturers Animal-derived Immune Globulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal-derived Immune Globulin Market Competitive Situation and Trends
2.5.1 Animal-derived Immune Globulin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal-derived Immune Globulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin as of 2022)
2.7 Date of Key Manufacturers Enter into Animal-derived Immune Globulin Market
2.8 Key Manufacturers Animal-derived Immune Globulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal-derived Immune Globulin Status and Outlook by Region
3.1 Global Animal-derived Immune Globulin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Animal-derived Immune Globulin Historic Market Size by Region
3.2.1 Global Animal-derived Immune Globulin Sales in Volume by Region (2018-2023)
3.2.2 Global Animal-derived Immune Globulin Sales in Value by Region (2018-2023)
3.2.3 Global Animal-derived Immune Globulin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Animal-derived Immune Globulin Forecasted Market Size by Region
3.3.1 Global Animal-derived Immune Globulin Sales in Volume by Region (2024-2029)
3.3.2 Global Animal-derived Immune Globulin Sales in Value by Region (2024-2029)
3.3.3 Global Animal-derived Immune Globulin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Animal-derived Immune Globulin by Application
4.1 Animal-derived Immune Globulin Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Animal-derived Immune Globulin Market Size by Application
4.2.1 Global Animal-derived Immune Globulin Market Size Overview by Application (2018-2029)
4.2.2 Global Animal-derived Immune Globulin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Animal-derived Immune Globulin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal-derived Immune Globulin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Animal-derived Immune Globulin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Animal-derived Immune Globulin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Animal-derived Immune Globulin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Animal-derived Immune Globulin Sales Breakdown by Application (2018-2023)
5 North America Animal-derived Immune Globulin by Country
5.1 North America Animal-derived Immune Globulin Historic Market Size by Country
5.1.1 North America Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Animal-derived Immune Globulin Sales in Volume by Country (2018-2023)
5.1.3 North America Animal-derived Immune Globulin Sales in Value by Country (2018-2023)
5.2 North America Animal-derived Immune Globulin Forecasted Market Size by Country
5.2.1 North America Animal-derived Immune Globulin Sales in Volume by Country (2024-2029)
5.2.2 North America Animal-derived Immune Globulin Sales in Value by Country (2024-2029)
6 Europe Animal-derived Immune Globulin by Country
6.1 Europe Animal-derived Immune Globulin Historic Market Size by Country
6.1.1 Europe Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Animal-derived Immune Globulin Sales in Volume by Country (2018-2023)
6.1.3 Europe Animal-derived Immune Globulin Sales in Value by Country (2018-2023)
6.2 Europe Animal-derived Immune Globulin Forecasted Market Size by Country
6.2.1 Europe Animal-derived Immune Globulin Sales in Volume by Country (2024-2029)
6.2.2 Europe Animal-derived Immune Globulin Sales in Value by Country (2024-2029)
7 Asia-Pacific Animal-derived Immune Globulin by Region
7.1 Asia-Pacific Animal-derived Immune Globulin Historic Market Size by Region
7.1.1 Asia-Pacific Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Animal-derived Immune Globulin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Animal-derived Immune Globulin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Animal-derived Immune Globulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal-derived Immune Globulin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Animal-derived Immune Globulin Sales in Value by Region (2024-2029)
8 Latin America Animal-derived Immune Globulin by Country
8.1 Latin America Animal-derived Immune Globulin Historic Market Size by Country
8.1.1 Latin America Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Animal-derived Immune Globulin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Animal-derived Immune Globulin Sales in Value by Country (2018-2023)
8.2 Latin America Animal-derived Immune Globulin Forecasted Market Size by Country
8.2.1 Latin America Animal-derived Immune Globulin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Animal-derived Immune Globulin Sales in Value by Country (2024-2029)
9 Middle East and Africa Animal-derived Immune Globulin by Country
9.1 Middle East and Africa Animal-derived Immune Globulin Historic Market Size by Country
9.1.1 Middle East and Africa Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Animal-derived Immune Globulin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Animal-derived Immune Globulin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Animal-derived Immune Globulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal-derived Immune Globulin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Animal-derived Immune Globulin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Animal-derived Immune Globulin Products Offered
10.1.5 Pfizer Recent Development
10.2 Rare Disease Therapeutics
10.2.1 Rare Disease Therapeutics Company Information
10.2.2 Rare Disease Therapeutics Introduction and Business Overview
10.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Offered
10.2.5 Rare Disease Therapeutics Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Animal-derived Immune Globulin Products Offered
10.3.5 Merck Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Animal-derived Immune Globulin Products Offered
10.4.5 Sanofi Recent Development
10.5 Wyeth Pharmaceuticals
10.5.1 Wyeth Pharmaceuticals Company Information
10.5.2 Wyeth Pharmaceuticals Introduction and Business Overview
10.5.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Wyeth Pharmaceuticals Animal-derived Immune Globulin Products Offered
10.5.5 Wyeth Pharmaceuticals Recent Development
10.6 Protherics
10.6.1 Protherics Company Information
10.6.2 Protherics Introduction and Business Overview
10.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Protherics Animal-derived Immune Globulin Products Offered
10.6.5 Protherics Recent Development
10.7 Genzyme
10.7.1 Genzyme Company Information
10.7.2 Genzyme Introduction and Business Overview
10.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Genzyme Animal-derived Immune Globulin Products Offered
10.7.5 Genzyme Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal-derived Immune Globulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal-derived Immune Globulin Industrial Chain Analysis
11.4 Animal-derived Immune Globulin Market Dynamics
11.4.1 Animal-derived Immune Globulin Industry Trends
11.4.2 Animal-derived Immune Globulin Market Drivers
11.4.3 Animal-derived Immune Globulin Market Challenges
11.4.4 Animal-derived Immune Globulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal-derived Immune Globulin Distributors
12.3 Animal-derived Immune Globulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
